Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. Regulatory Recon is ...

The US Food and Drug Administration (FDA) announced on Tuesday the launch of a pilot program designed to expedite the review ...

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. In Foc ...

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.

A panel of experts representing the European Commission, industry, and notified bodies reviewed the state discussed the ...

Experts in medical device and pharmaceutical regulatory affairs discussed how the field has evolved over the last five ...

The European Medicines Agency (EMA) has published a guideline on evaluating drug interactions in the gastrointestinal tract ...

RAPS Convergence 2026 is an opportunity for regulatory professionals to reflect on the evolution of the profession, look ...

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.

Commissioner Robert Califf was a medical student in the mid-1970s, he had an opportunity to work with his mentor on one of ...

This week, a Senate committee scheduled a hearing for President Trump’s nominee to lead FDA, new reporting sheds light on the ...